← Back to Search

Behavioral Intervention

Drinking Dashboard for Reducing Blackout Drinking Risks

N/A
Waitlist Available
Led By Mary Beth Miller, PhD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to follow-up (1 and 3 months)
Awards & highlights

Summary

This trial tests a tool called the 'Drinking Dashboard' that provides feedback on drinking risks for young adults who have experienced blackouts. The goal is to help them reduce their drinking by making them aware of the dangers associated with blackouts.

Who is the study for?
This study is for young adults aged 18-30 who binge drink weekly and have experienced any form of alcohol-induced memory loss in the past month. It's not suitable for individuals with urgent psychiatric needs like psychosis or severe suicidal thoughts.
What is being tested?
The trial is testing a 'Drinking Dashboard,' which gives participants weekly feedback on their drinking habits, specifically focusing on risk factors and consequences related to blackouts from alcohol use.
What are the potential side effects?
Since this intervention involves providing information rather than medication, traditional side effects are not expected. However, there may be psychological impacts from receiving personal feedback about risky behaviors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to follow-up (1 and 3 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to follow-up (1 and 3 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Alcohol-related consequences
Frequency of blackouts
+4 more
Secondary study objectives
Blackout self-efficacy
Blackout severity
Blackout susceptibility
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Drinking DashboardExperimental Treatment1 Intervention
Day-level feedback on alcohol use and consequences
Group II: Assessment OnlyActive Control1 Intervention
Daily assessment control group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Drinking Dashboard
2023
N/A
~170

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Educational feedback interventions, such as those studied in the Drinking Dashboard trial, work by providing personalized feedback on drinking patterns, risk factors, and consequences of alcohol use. This approach increases awareness and motivates behavior change by highlighting the risks associated with excessive drinking. For patients, this means gaining critical knowledge and self-awareness, which are essential for reducing alcohol consumption and maintaining healthier drinking behaviors.
Effectiveness of brief alcohol interventions in primary care populations.Ultra-brief intervention for problem drinkers: results from a randomized controlled trial.Brief interventions for heavy alcohol users admitted to general hospital wards.

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
377 Previous Clinical Trials
628,544 Total Patients Enrolled
Mary Beth Miller, PhDPrincipal InvestigatorUniversity of Missouri-Columbia
2 Previous Clinical Trials
123 Total Patients Enrolled

Media Library

Drinking Dashboard (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05630625 — N/A
Alcohol Consumption Research Study Groups: Assessment Only, Drinking Dashboard
Alcohol Consumption Clinical Trial 2023: Drinking Dashboard Highlights & Side Effects. Trial Name: NCT05630625 — N/A
Drinking Dashboard (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05630625 — N/A
~72 spots leftby Oct 2025